| 臺大學術典藏 |
2022-04-15T03:00:29Z |
Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis
|
Gelmon, Karen A; Fasching, Peter A; Couch, Fergus J; Balmaña, Judith; Delaloge, Suzette; Labidi-Galy, Intidhar; Bennett, James; CHIUN-SHENG HUANG; et al. |
| 臺大學術典藏 |
2022-04-15T02:58:07Z |
Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE
|
Mamounas, E P; Untch, M; Mano, M S; CHIUN-SHENG HUANG; Geyer, C E; von Minckwitz, G; Wolmark, N; ...et al. |
| 臺大學術典藏 |
2022-04-15T02:52:03Z |
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
|
Burstein, H J; Curigliano, G; Thürlimann, B; Weber, W P; Poortmans, P; Regan, M M; Senn, H J; Winer, E P; Gnant, M; CHIUN-SHENG HUANG; ...et al. |
| 臺大學術典藏 |
2022-04-15T02:46:33Z |
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
|
Lin, Po-Han; Wang, Ming-Yang; Lo, Chiao; Tsai, Li-Wei; Yen, Tzu-Chun; Huang, Thomas Yoyan; Huang, Wei-Chih; Yang, Karen; Chen, Chih-Kai; Fan, Sheng-Chih; Kuo, Sung-Hsin; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2022-04-15T02:44:47Z |
High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia
|
Lin, Ching-Hung; Huang, Ruby Yun-Ju; Lu, Tzu-Pin; Kuo, Kuan-Ting; Lo, Ko-Yun; Chen, Ching-Hsuan; Chen, I-Chun; Lu, Yen-Shen; Chuang, Eric Y; Thiery, Jean Paul; CHIUN-SHENG HUANG; Cheng, Ann-Lii |
| 臺大學術典藏 |
2022-04-15T02:42:33Z |
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
|
Harbeck, N; Rastogi, P; Martin, M; Tolaney, S M; Shao, Z M; Fasching, P A; CHIUN-SHENG HUANG; Jaliffe, G G; Tryakin, A; Goetz, M P; Rugo, H S; Senkus, E; Testa, L; Andersson, M; Tamura, K; Del Mastro, L; Steger, G G; Kreipe, H; Hegg, R; Sohn, J; Guarneri, V; Cortés, J; Hamilton, E; André, V; Wei, R; Barriga, S; Sherwood, S; Forrester, T; Munoz, M; Shahir, A; San Antonio, B; Nabinger, S C; Toi, M; Johnston, S R D; O'Shaughnessy, J |
| 臺大學術典藏 |
2022-04-15T02:40:38Z |
Factors predicting one or two sentinel lymph nodes to be accepted for sentinel lymph node biopsy alone after neoadjuvant therapy in initially node-positive breast cancer patients
|
Tsai, Li-Wei; Lee, Yi-Hsuan; Lo, Chiao; Lien, Huang-Chun; Wang, Ming-Yang; Jan, I-Shiow; Yen, Ruoh-Fang; Hu, Fu-Chang; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2022-04-15T02:38:31Z |
Correlation of ER, PR, and HER2 at the protein and mRNA levels in Asian patients with operable breast cancer
|
Chen, Chih-Jung; Chen, Ting-Hao; Lei, Jason; Liang, Ji-An; Yang, Po-Sheng; CHIUN-SHENG HUANG; Hsieh, Chia-Ming; Tseng, Ling-Ming; Liu, Liang-Chih; Cheng, Skye Hung-Chen; Shih, Kuan-Hui |
| 臺大學術典藏 |
2022-04-15T02:35:15Z |
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study
|
Gianni, L; CHIUN-SHENG HUANG; Egle, D; Bermejo, B; Zamagni, C; Thill, M; Anton, A; Zambelli, S; Bianchini, G; Russo, S; Ciruelos, E M; Greil, R; Semiglazov, V; Colleoni, M; Kelly, C; Mariani, G; Del Mastro, L; Maffeis, I; Valagussa, P; Viale, G |
| 臺大學術典藏 |
2022-04-15T02:33:29Z |
Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study
|
Krop, Ian E; Im, Seock-Ah; Barrios, Carlos; Bonnefoi, Hervé; Gralow, Julie; Toi, Masakazu; Ellis, Paul A; Gianni, Luca; Swain, Sandra M; Im, Young-Hyuck; De Laurentiis, Michelino; Nowecki, Zbigniew; CHIUN-SHENG HUANG; Fehrenbacher, Louis; Ito, Yoshinori; Shah, Jigna; Boulet, Thomas; Liu, Haiying; Macharia, Harrison; Trask, Peter; Song, Chunyan; Winer, Eric P; Harbeck, Nadia |
| 臺大學術典藏 |
2022-04-15T02:31:40Z |
Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients
|
Lin, Po-Han; Chen, Shin-Cheh; Tseng, Ling-Ming; Chang, King-Jen; Huang, Ai-Chu; Cheng, Kuo-Chih; Yang, Karen; Wu, Hui-Chen; Chao, Tsu-Yi; Chang, Yuan-Ching; Lin, Peng-Chan; Kuo, Wen-Hung; Kuo, Wen-Lin; Lin, Ching-Hung; Chen, Huo-Mu; Yeh, Dah-Cherng; Liu, Liang-Chih; Liu, Chun-Yu; Wang, Ming-Yang; Lo, Chiao; Lu, Yen-Shen; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2022-04-15T02:29:49Z |
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial
|
Hickish, Tamas; Mehta, Ajay; Liu, Mei-Ching; CHIUN-SHENG HUANG; Arora, Rajendra Singh; Chang, Yuan-Ching; Yang, Youngsen; Vladimirov, Vladimir; Jain, Minish; Tsang, Janice; Pemberton, Karine; Sadrolhefazi, Behbood; Jin, Xidong; Tseng, Ling-Ming |
| 臺大學術典藏 |
2022-03-14T23:45:40Z |
Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients
|
PO-HAN LIN; Chen, Shin Cheh; Tseng, Ling Ming; Chang, King Jen; Huang, Ai Chu; Cheng, Kuo Chih; Yang, Karen; Wu, Hui Chen; Chao, Tsu Yi; Chang, Yuan Ching; Lin, Peng Chan; WEN-HUNG KUO; Kuo, Wen Lin; CHING-HUNG LIN; Chen, Huo Mu; Yeh, Dah Cherng; Liu, Liang Chih; Liu, Chun Yu; Wang, Ming Yang; Lo, Chiao; YEN-SHEN LU; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2021-12-14T23:12:34Z |
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
|
PO-HAN LIN; Wang, Ming Yang; Lo, Chiao; Tsai, Li Wei; Yen, Tzu Chun; Huang, Thomas Yoyan; Huang, Wei Chih; Yang, Karen; Chen, Chih Kai; Fan, Sheng Chih; SUNG-HSIN KUO; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2021-12-14T23:11:56Z |
Factors predicting one or two sentinel lymph nodes to be accepted for sentinel lymph node biopsy alone after neoadjuvant therapy in initially node-positive breast cancer patients
|
Tsai, Li Wei; Lee, Yi Hsuan; Lo, Chiao; HUANG-CHUN LIEN; Wang, Ming Yang; I-SHIOW JAN; RUOH-FANG YEN; Hu, Fu Chang; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2021-09-14T23:19:03Z |
High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia
|
CHING-HUNG LIN; RUBY YUN-JU HUANG; TZU-PIN LU; KUAN-TING KUO; Lo, Ko Yun; Chen, Ching Hsuan; Chen, I. Chun; YEN-SHEN LU; Chuang, Eric Y.; Thiery, Jean Paul; CHIUN-SHENG HUANG; ANN-LII CHENG |
| 臺大學術典藏 |
2021-06-04T05:14:13Z |
Computer-aided diagnosis of breast ultrasound images using ensemble learning from convolutional neural networks
|
Moon, Woo Kyung; Lee, Yan-Wei; Ke, Hao-Hsiang; Lee, Su Hyun; CHIUN-SHENG HUANG; Chang, Ruey-Feng |
| 臺大學術典藏 |
2021-06-04T05:10:19Z |
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study
|
CHIUN-SHENG HUANG; Yang, Youngsen; Kwong, Ava; Chen, Shin-Cheh; Tseng, Ling-Ming; Liu, Mei-Ching; Shen, Kunwei; Wang, Shusen; Ng, Ting-Ying; Feng, Yi; Sun, Guofang; Yan, Iris Renfei; Shao, Zhimin |
| 臺大學術典藏 |
2021-04-26T08:05:28Z |
Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study
|
CHIUN-SHENG HUANG; Yu A.L.; Tseng L.-M.; Chow L.W.C.; Hou M.-F.; Hurvitz S.A.; Schwab R.B.; L Murray J.; Chang H.-K.; Chang H.-T.; Chen S.-C.; Kim S.-B.; Hung J.-T.; Ueng S.-H.; Lee S.-H.; Chen C.-C.; Rugo H.S. |
| 臺大學術典藏 |
2021-04-26T08:05:28Z |
Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2–positive breast cancer
|
Conte P.;Schneeweiss A.;Loibl S.;Mamounas E.P.;Von Minckwitz G.;Mano M.S.;Untch M.;Chiun-Sheng Huang;Wolmark N.;Rastogi P.;D’Hondt V.;Redondo A.;Stamatovic L.;Bonnefoi H.;Castro-Salguero H.;Fischer H.H.;Wahl T.;Song C.;Boulet T.;Trask P.;Geyer C.E.;Jr.; Conte P.; Schneeweiss A.; Loibl S.; Mamounas E.P.; von Minckwitz G.; Mano M.S.; Untch M.; CHIUN-SHENG HUANG; Wolmark N.; Rastogi P.; D’Hondt V.; Redondo A.; Stamatovic L.; Bonnefoi H.; Castro-Salguero H.; Fischer H.H.; Wahl T.; Song C.; Boulet T.; Trask P.; Geyer C.E.; Jr. |
| 臺大學術典藏 |
2021-04-26T08:05:27Z |
Investigating the association of the biogenic amine profile in urine with therapeutic response to neoadjuvant chemotherapy in breast cancer patients
|
Chiun-Sheng Huang;Kuo C.-H.;Kuoch@Ntu.Edu.Tw, Lo C.;Hsu Y.-L.;Cheng C.-N.;Lin C.-H.;Kuo H.-C.; CHIUN-SHENG HUANG; Kuo C.-H.; Kuoch@ntu.edu.tw, Lo C.; Hsu Y.-L.; Cheng C.-N.; Lin C.-H.; Kuo H.-C. |
| 臺大學術典藏 |
2021-04-26T08:05:27Z |
A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women
|
Tsai M.-S.; Chang S.-H.; Kuo W.-H.; Kuo C.-H.; Li S.-Y.; Wang M.-Y.; Chang D.-Y.; Lu Y.-S.; CHIUN-SHENG HUANG; Cheng A.-L.; Lin C.-H.; Chen P.-C. |
| 臺大學術典藏 |
2021-04-26T08:05:27Z |
Palbociclib and beyond for the treatment of HR + HER2- metastatic breast cancer: an Asian-Pacific perspective and practical management guide on the use of CDK4/6 inhibitors
|
Dawood S.;Chiu J.W.-Y.;Chiun-Sheng Huang;Nag S.;Sookprasert A.;Yap Y.-S.;Md Yusof M.; Dawood S.; Chiu J.W.-Y.; CHIUN-SHENG HUANG; Nag S.; Sookprasert A.; Yap Y.-S.; Md Yusof M. |
| 臺大學術典藏 |
2021-04-26T08:05:27Z |
Computer?aided diagnosis of breast ultrasound images using ensemble learning from convolutional neural networks
|
Moon W.K.;Lee Y.-W.;Ke H.-H.;Lee S.H.;Chiun-Sheng Huang;Chang R.-F.; Moon W.K.; Lee Y.-W.; Ke H.-H.; Lee S.H.; CHIUN-SHENG HUANG; Chang R.-F. |
| 臺大學術典藏 |
2021-04-26T08:05:26Z |
Automated whole breast segmentation for hand-held ultrasound with position information: Application to breast density estimation
|
Chang J.-F.;Chiun-Sheng Huang;Chang R.-F.; Chang J.-F.; CHIUN-SHENG HUANG; Chang R.-F. |
| 臺大學術典藏 |
2021-04-26T08:05:25Z |
Artificial Intelligence Aids Cardiac Image Quality Assessment for Improving Precision in Strain Measurements
|
Huang K.-C.; CHIUN-SHENG HUANG; Su M.-Y.; Hung C.-L.; Ethan Tu Y.-C.; Lin L.-C.; Hwang J.-J. |
| 臺大學術典藏 |
2021-04-26T08:05:25Z |
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
|
Cortes J.; Cescon D.W.; Rugo H.S.; Nowecki Z.; Im S.-A.; Yusof M.M.; Gallardo C.; Lipatov O.; Barrios C.H.; Holgado E.; Iwata H.; Masuda N.; Otero M.T.; Gokmen E.; Loi S.; Guo Z.; Zhao J.; Aktan G.; Karantza V.; Schmid P.; Luis F.; Gonzalo G.A.; Diego K.; Ruben K.; Matias M.; Mirta V.; Sally B.-H.; Stephen B.; Philip C.; Sherene L.; Dhanusha S.; Andrea G.; Donatienne T.; Carlos B.; Leandro B.; Fabiano C.; Ruffo D.F.J.; Roberto H.; Domicio Carvalho L.; Fernando Cezar Toniazzi L.; Roberto Odebrecht R.; Antonio Orlando S.N.; Felipe S.; David C.; Danielle C.; Cristiano F.; Xinni S.; Joanne Y.; Alejandro A.; Carlos G.; Claudio S.; Cesar S.; Eduardo Y.; Alvaro G.D.; Jesus S.; Petra H.; Zdenek K.; Bohuslav M.; Katarina P.; Jana P.; Vesna G.; Erik J.; Jeanette J.; Soren L.; Tamas L.; Herve B.; Isabelle D.; Anthony G.; Anne-Claire H.-B.; Luis T.; Jens-Uwe B.; Peter F.; Dirk F.; Nadia H.; Jens H.; Anna K.F.D.S.; Christian K.; Sibylle L.; Diana L.; Tjoung-Won P.-S.; Raquel Von S.; Pauline W.; Louis C.; Ava K.; Kai Cheong Roger N.; Peter A.; Tibor C.; Zsuzsanna K.; Laszlo L.; Karoly M.; Gabor R.; John C.; Catherine K.; Seamus O.R.; Saverio C.; Antonietta D.A.; Enrico R.; Tomoyuki A.; Takaaki F.; Kenichi I.; Takashi I.; Yoshinori I.; Tsutomu I.; Hiroji I.; Yoshimasa K.; Koji M.; Yasuo M.; Hirofumi M.; Seigo N.; Naoki N.; Shoichiro O.; Akihiko O.; Yasuaki S.; Eiji S.; Masato T.; Yuko T.; Kenji T.; Koichiro T.; Junichiro W.; Naohito Y.; Yutaka Y.; Teruo Y.; Anita B.; Mastura M.Y.; Angel G.V.; Alejandro J.R.; Jorge M.R.; Flavia M.-V.; Jessica R.C.; Karin B.; Vivianne T.-H.; David P.; Ewa C.; Ewa N.-Z.; Zbigniew N.; Barbara R.; Joanna S.; Cezary S.; Rafal T.; Bogdan Z.; Alexander A.; Natalia F.; Oleg L.; Andrey M.; Vladimir M.; Guzel M.; Jin Hee A.; Seock-Ah I.; Keun Seok L.; Kwong Hwa P.; Yeon Hee P.; Begona B.D.L.H.; Javier C.; Josefina C.J.; Luis D.L.C.M.; Jose G.S.; Maria G.; Esther H.; Esther Z.A.; Chien-Ting L.; Mei-Ching L.; Chiun-Sheng H.; Chao-Jung T.; Ling-Ming T.; Cagatay A.; Gul B.; Irfan C.; Erhan G.; Seyda G.; Nil M.M.; Mustafa O.; Ozgur O.; Sinan Y.; Steve C.; Janine G.; Iain M.; Peter S.; Nicholas T.; Mark T.; Christopher T.; Duncan W.; Hryhoriy A.; Oleksandr B.; Igor B.; Oleksii K.; Olena K.; Hanna K.; Anna K.; Iurii L.; Alla N.; Natalya O.; Olga P.; Andrii R.; Sergii S.; Yaroslav S.; Dmytro T.; Grygorii U.; Ihor V.; Sibel B.; Madhu C.; Michael C.; Patrick C.; Scott C.; Jennifer D.; Keerthi G.; Jeffrey H.; Kent H.; William I.; Randa L.; Janice L.; Raul M.; Susan M.; Rita N.; Ira O.; Coral O.; Timothy P.; Amit P.; Brian P.; Hope R.; Irina R.; Michael S.; Robert S.; Michael S.; Laura S.; Bradley S.; Michaela T.; Frances V.-A.; KEYNOTE-355 Investigators; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2021-04-26T08:05:25Z |
Axillary lymph node metastasis status prediction of early-stage breast cancer using convolutional neural networks
|
Lee Y.-W.; CHIUN-SHENG HUANG; Shih C.-C.; Chang R.-F. |
| 臺大學術典藏 |
2021-04-26T08:05:24Z |
Pertuzumab and trastuzumab as adjuvant treatment for HER2-positive early breast cancer: outcomes in Chinese patients in the APHINITY study
|
Shao Z.; Tseng L.-M.; CHIUN-SHENG HUANG; Pang D.; Yang Y.; Li W.; Liao N.; Geng C.; Zhang Q.; Xu B.; Liu D.; Kwong A.; et al (continued in the appendix) |
| 臺大學術典藏 |
2021-01-19T12:08:35Z |
Axillary lymph node metastasis status prediction of early-stage breast cancer using convolutional neural networks
|
Lee, Yan Wei; CHIUN-SHENG HUANG; Shih, Chung Chih; RUEY-FENG CHANG |
| 臺大學術典藏 |
2020-05-21T09:04:57Z |
Prognostic factors for the survival of Taiwanese breast cancer patients
|
Wei-Chu Chie;Shu-Hui Chang;Chiun-Sheng Huang;Tzeng, Shinn-Jia;Chen, Jen-Hau;Fan, Bih-Yuh;Chang, King-Jen; WEI-CHU CHIE; SHU-HUI CHANG; CHIUN-SHENG HUANG; Tzeng, Shinn-Jia; Chen, Jen-Hau; Fan, Bih-Yuh; Chang, King-Jen |
| 臺大學術典藏 |
2020-03-23T07:19:43Z |
The changes of serum titers of thyroid antibodies in patients of Graves' disease with hyperthyroidism after treatments with antithyroid drugs
|
Chiun-Sheng Huang;Tseng F.Y.;Chang T.C.; CHIUN-SHENG HUANG; Tseng F.Y.; Chang T.C. |
| 臺大學術典藏 |
2020-03-23T07:19:42Z |
Photodynamic effect on breast and colon cancer cells of use of merocyanine 540 as a photosensitizer
|
Chiun-Sheng Huang;Huang S.-H.;Lin T.-I.;Chang K.-J.; CHIUN-SHENG HUANG; Huang S.-H.; Lin T.-I.; Chang K.-J. |
| 臺大學術典藏 |
2020-03-23T07:19:42Z |
HER-2/neu overexpression in Chinese breast cancers: correlation with other prognostic factors.
|
CHIUN-SHENG HUANG; Chen Y.C.; Wang M.; Lin J.K.; Chang K.J.; Chiun-Sheng Huang;Chen Y.C.;Wang M.;Lin J.K.;Chang K.J. |
| 臺大學術典藏 |
2020-03-23T07:19:42Z |
The changes of serum titers of thyroid antibodies in patients of Graves' disease with hyperthyroidism after treatments with antithyroid drugs.
|
Chang T.C.; Chang C.C.; Chen F.W.; Torng J.K.; Chiun-Sheng Huang;Tseng F.Y.;Chang T.C.;Chang C.C.;Chen F.W.;Torng J.K.; CHIUN-SHENG HUANG; Tseng F.Y. |
| 臺大學術典藏 |
2020-03-23T07:19:41Z |
Breast cancer in Taiwan
|
Chie W.-C.; CHIUN-SHENG HUANG; Chang K.-J.; Chie W.-C.;Chiun-Sheng Huang;Chang K.-J. |
| 臺大學術典藏 |
2020-03-23T07:19:41Z |
Total colonoscopy in patients with polyps in the proctosigmoid region - A Taiwanese experience
|
Shieh M.-J.;Wang C.-Y.;Wong J.-M.;Chiun-Sheng Huang;Huang S.-H.; Shieh M.-J.; Wang C.-Y.; Wong J.-M.; CHIUN-SHENG HUANG; Huang S.-H. |
| 臺大學術典藏 |
2020-03-23T07:19:40Z |
Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma
|
Yu A.L.; Uttenreuther-Fischer M.M.; CHIUN-SHENG HUANG; Tsui C.C.; Gillies S.D.; Reisfeld R.A.; Kung F.H. |
| 臺大學術典藏 |
2020-03-23T07:19:40Z |
Characterization of an allelic variant in the nifedipine-specific element of CYP3A4: ethnic distribution and implications for prostate cancer risk. Mutations in brief no. 191. Online.
|
Rebbeck T.R.; Olopade O.I.; Weber B.L.; Chern H.D.; CHIUN-SHENG HUANG; Cummings S.A.; Gunasegaram S.; Jaffe J.M.; Walker A.H. |
| 臺大學術典藏 |
2020-03-23T07:19:39Z |
The prognostic significance of tumor angiogenesis in Taiwanese patients with invasive ductal breast carcinomas
|
Chang K.-J.; CHIUN-SHENG HUANG; Chu J.-S.; Chang K.-J.;CHIUN-SHENG HUANG;Chu J.-S. |
| 臺大學術典藏 |
2020-03-23T07:19:39Z |
Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in invasive ductal carcinoma of the breast in Taiwan
|
Chang K.-J.;CHIUN-SHENG HUANG;Chu J.-S.; Chu J.-S.; CHIUN-SHENG HUANG; Chang K.-J. |
| 臺大學術典藏 |
2020-03-23T07:19:38Z |
Measurement of the quality of life during different clinical phases of breast cancer
|
Chie W.-C.;Chiun-Sheng Huang;Chen J.-H.;Chang K.-J.; Chie W.-C.; CHIUN-SHENG HUANG; Chen J.-H.; Chang K.-J. |
| 臺大學術典藏 |
2020-03-23T07:19:38Z |
Microcalcifications of non-palpable breast lesions detected by ultrasonography: Correlation with mammography and histopathology
|
Chiun-Sheng Huang;Wu C.-Y.;Chu J.-S.;Lin J.-H.;Hsu S.-M.;Chang K.-J.; CHIUN-SHENG HUANG; Wu C.-Y.; Chu J.-S.; Lin J.-H.; Hsu S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2020-03-23T07:19:38Z |
Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan
|
Chiun-Sheng Huang;Shen C.-Y.;Chang K.-J.;Hsu S.-M.;Chern H.-D.; CHIUN-SHENG HUANG; Shen C.-Y.; Chang K.-J.; Hsu S.-M.; Chern H.-D. |
| 臺大學術典藏 |
2020-03-23T07:19:38Z |
p27 expression as a prognostic factor of breast cancer in Taiwan
|
Chu J.-S.;Chiun-Sheng Huang;Chang K.-J.; Chu J.-S.; CHIUN-SHENG HUANG; Chang K.-J. |
| 臺大學術典藏 |
2020-03-23T07:19:37Z |
Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: An implication for mutator phenotype and breast cancer pathogenesis
|
Shen C.-Y.; Yu J.-C.; Lo Y.-L.; Kuo C.-H.; Yue C.-T.; Jou Y.-S.; CHIUN-SHENG HUANG; Lung J.-C.; Wu C.-W.; Shen C.-Y.;Yu J.-C.;Lo Y.-L.;Kuo C.-H.;Yue C.-T.;Jou Y.-S.;Chiun-Sheng Huang;Lung J.-C.;Wu C.-W. |
| 臺大學術典藏 |
2020-03-23T07:19:36Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Hsu C.;Chiun-Sheng Huang;Chao T.-Y.;Lu Y.-S.;Bu C.-F.;Chen M.M.;Chang K.-J.;Cheng A.-L.; Hsu C.; CHIUN-SHENG HUANG; Chao T.-Y.; Lu Y.-S.; Bu C.-F.; Chen M.M.; Chang K.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-23T07:19:36Z |
Mechanisms of inactivation of E-cadherin in breast carcinoma: Modification of the two-hit hypothesis of tumor suppressor gene
|
Cheng C.-W.;Wu P.-E.;Yu J.-C.;Chiun-Sheng Huang;Yue C.-T.;Wu C.-W.;Shen C.-Y.; Cheng C.-W.; Wu P.-E.; Yu J.-C.; CHIUN-SHENG HUANG; Yue C.-T.; Wu C.-W.; Shen C.-Y. |
| 臺大學術典藏 |
2020-03-23T07:19:36Z |
Breast cancer screening in Taiwan and China
|
Chiun-Sheng Huang;Chang K.-J.;Shen C.-Y.; CHIUN-SHENG HUANG; Chang K.-J.; Shen C.-Y. |
| 臺大學術典藏 |
2020-03-23T07:19:36Z |
Prognostic factors for the survival of Taiwanese breast cancer patients
|
Chang K.-J.; Fan B.-Y.; Chen J.-H.; Tzeng S.-J.; CHIUN-SHENG HUANG; Chang S.-H.; Chie W.-C.; Chie W.-C.;Chang S.-H.;Chiun-Sheng Huang;Tzeng S.-J.;Chen J.-H.;Fan B.-Y.;Chang K.-J. |
